Xcout Intel
Eureka Therapeutics Inc competitors & alternatives
The 12 closest competitors and alternatives to Eureka Therapeutics Inc among biotechnology companies — ranked by similarity to what Eureka Therapeutics Inc actually does, not by market-cap band.
Subscribe to see Eureka Therapeutics Inc’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Eureka Therapeutics Inc
Eureka Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing transformative technology platforms and first-in-class T-cell therapies to access cancer-specific targets.
Eureka Therapeutics Inc at a glance
Eureka Therapeutics Inc is a biotechnology company headquartered in United States. Its most recent funding round raised $20M in May 2023. Xcout tracks 1 named person at Eureka Therapeutics Inc, including Alexa Willson (Chief Financial Officer).
Eureka Therapeutics Inc leadership
- Alexa WillsonChief Financial Officer
Eureka Therapeutics Inc funding rounds
The 6 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $20M | — | |
| SEC Form D filing | $45M | — | |
| — | $60M | 1 named | |
| SEC Form D filing | $20M | — | |
| SEC Form D filing | $40M | — | |
| Series C | $21M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Eureka Therapeutics Inc competitors
Ranked by semantic similarity — how close each company is to Eureka Therapeutics Inc by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotech
Excalipoint Therapeutics is a clinical-stage biotechnology company headquartered in Shanghai, China. The firm is dedicated to developing next-generation T-cell engager (TCE) therapies and unlocking the therapeutic potential of T-cell based treatments.
Biotech
Eutilex is a biopharmaceutical company that develops innovative immunotherapeutics, including antibody treatments, T-cell therapies, and CAR-T cell therapies. The company focuses on creating treatments for incurable and intractable diseases through continuous research and development.
Biotech
A clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered tumor-infiltrating lymphocyte (TIL) cell therapies for the treatment of patients with solid tumors. Its proprietary cytoDRiVE® technology is designed to precisely regulate the timing and level of protein function by using FDA-approved small-molecule drugs.
Biotech
Elicera Therapeutics is a clinical-stage immuno-oncology company that develops genetically engineered cell and gene therapies, including CAR T-cell therapies and oncolytic viruses, to treat various types of cancer. The company utilizes its proprietary iTANK technology platform to enhance the immune system's ability to target and attack solid tumors.
Similar biotechnology company
Revolution Medicines is a clinical-stage oncology company that develops novel targeted therapies to outsmart cancer. The company focuses on discovering and advancing therapeutic pipelines for patients with difficult-to-treat tumors.
Similar biotechnology company
CytoImmune Therapeutics is a clinical-stage biotechnology company headquartered in Duarte, California, focused on developing novel cell therapies for cancer treatment.
Similar biotechnology company
T3 Pharmaceuticals AG is a biotechnology company that develops a proprietary technology platform utilizing bacteria to deliver targeted therapies. The company focuses on advancing a pipeline of Immuno-Oncology products designed to treat cancer patients.
Similar biotechnology company
Affini-T Therapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered in Watertown, Massachusetts, specializing in the development of precision immunotherapies and T-cell therapies for cancer patients.
Biotech
Tessa Therapeutics is a clinical-stage biotechnology company with its global headquarters in Singapore. The company focuses on developing next-generation cell therapies for cancer and opened a commercial-scale cell therapy manufacturing facility in Singapore in 2020.
Similar biotechnology company
92Bio is a clinical-stage biotechnology company headquartered in Hayward, California, that develops next-generation T-cell engaging antibodies for therapeutic treatments.
Biotech
ArsenalBio is a biotechnology company developing programmable cell therapies, particularly engineered T-cell therapies, for cancer treatment. It serves biopharmaceutical and healthcare markets by using synthetic biology and genomic engineering to create more effective, controllable immune-cell medicines.
Similar biotechnology company
ME Therapeutics Holdings Inc. is a clinical-stage biotechnology company that discovers and develops immuno-oncology therapeutics designed to reprogram immune cells in vivo. Its pipeline aims to activate the body's immune system to recognize and fight cancer cells.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Eureka Therapeutics Inc and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Eureka Therapeutics Incand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →